CTRI/2023/03/050742尚未招募Unknown
EVALUATION OF INDICATIONS FOR BLOOD COMPONENTS TRANSFUSION IN OBSTETRICS
SHRI B M PATIL MEDICAL COLLEGE AND HOSPITA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All patients admitted to the obstetric unit requiring blood and blood products at Shri B.M. Patil Medical College and Hospital.
排除标准
- •- Patients with history of Congenital hematological disorders (Thalassemias, Immune Thrombocytopenic Purpura, Sickle cell Anaemia).
- •- Patients with history of Hematological malignancies
研究者
相似试验
尚未招募
Unknown
aboratory tests for identification of liver disease patients.CTRI/2024/05/067728Datta Meghe Institute of Higher Education and Research
尚未招募
1 期
Role of Snehapana on blood sugars and metabolismCTRI/2024/05/067863KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya
进行中（未招募）
4 期
Evaluation of concentrations in hemacea, plasma and total magnesium in patients submitted to chemotherapy with platinum compounds in association with proton pump inhibitors and their correlation with neurological diseaseseoplasmsMalignant neoplasm of other parts of pancreasMalignant neoplasm of rectumMalignant neoplasm of splenic flexureMalignant neoplasm of main bronchusUndescended testisMalignant neoplasm of ovaryHodgkin's diseaseMalignant neoplasm of head, face and neckMalignant neoplasm of breastIdiopathic peripheral autonomic neuropathyRBR-8vsb7k2IVERSIDADE FEDERAL DO RIO GRANDE DO NORTE
尚未招募
Unknown
To assess the prognostic value of blood-based indices in decompensated liver cirrhosisCTRI/2024/06/069600Vishal Balchand Padwale
招募中
不适用
Prediction of hematotoxicity and non-hematological toxicity of systemic therapies and other clinical outcome parameters for patients with locally advanced gastric cancer or gastroesophageal transition (AEG I-III by Siewert) and patients with pancreatic carcinomaC15C16C25Malignant neoplasm of oesophagusMalignant neoplasm of stomachMalignant neoplasm of pancreasDRKS00021415niversitäres Krebszentrum Leipzig (UCCL)35